ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 155 out of 780

$583K Total Retail Price of All Prescriptions

Rank: 242 out of 780

598 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 598 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 9,828 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 612 278 S3 1 1
AMLODIPINE BESYLATE 607 456 2 4
OMEPRAZOLE 546 365 3 3
LOSARTAN POTASSIUM 476 382 4 18
METFORMIN HCL 372 269 5 8
LEVOTHYROXINE SODIUM 362 275 6 5
ZOLPIDEM TARTRATE 345 207 7 17
SIMVASTATIN 343 268 8 2
FUROSEMIDE 251 199 9 7
MELOXICAM 239 187 10 16
LISINOPRIL 223 143 11 6
POTASSIUM CHLORIDE 206 175 12 11
LEVOFLOXACIN 198 148 13 76
TRAMADOL HCL 198 109 13 15
TRIAMTERENE-HCTZ 193 124 15 37
GABAPENTIN 191 116 16 13
PREDNISONE 191 170 16 40
WARFARIN SODIUM 177 99 18 24
GLIPIZIDE 166 117 19 74
HYDROCHLOROTHIAZIDE 162 149 20 10
NEXIUM 158 110 21 22
METOPROLOL TARTRATE 157 131 22 19
PRAVASTATIN SODIUM 157 108 22 9
GLIMEPIRIDE 154 115 24 30
SERTRALINE HCL 147 113 25 27
CLONIDINE HCL 144 97 26 28
CIPROFLOXACIN HCL 132 110 27 49
PANTOPRAZOLE SODIUM 124 105 28 25
MECLIZINE HCL 122 105 29 83
ATORVASTATIN CALCIUM 108 86 30 12
CLOPIDOGREL 107 76 31 34
CARVEDILOL 107 79 31 14
ALLOPURINOL 107 94 31 29
RANITIDINE HCL 104 66 34 39
CRESTOR 104 78 34 32
PROAIR HFA 103 42 36 62
AMOX TR-POTASSIUM CLAVULANATE 98 69 37 135
METOPROLOL SUCCINATE 97 90 38 20
KLOR-CON 10 97 88 38 90
ATENOLOL 96 58 40 21
ENALAPRIL MALEATE 95 61 41 64
AZITHROMYCIN 90 51 42 38
NIFEDIPINE ER 88 68 43 115
KLOR-CON M20 87 58 44 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 54 45 26
GEMFIBROZIL 84 83 46 104
BUMETANIDE 84 68 46 96
CYCLOBENZAPRINE HCL 84 34 R 46 42
CEFUROXIME 80 54 49 147
DIGOXIN 80 71 49 56
TAMSULOSIN HCL 79 64 51 36
FLUOXETINE HCL 76 30 52 65
ISOSORBIDE MONONITRATE ER 75 56 53 60
OXYCODONE HCL-ACETAMINOPHEN 72 0 S2 54 146
DOXYCYCLINE HYCLATE 70 39 55 103
HYDRALAZINE HCL 70 57 55 54
TERAZOSIN HCL 69 41 57 160
LOSARTAN-HYDROCHLOROTHIAZIDE 69 44 57 33
PRAMIPEXOLE DIHYDROCHLORIDE 67 48 59 156
PLAVIX 67 53 59 45
DIOVAN 66 54 61 55
PAROXETINE HCL 64 53 62 69
CYMBALTA 64 46 62 51
PROMETHAZINE HCL 61 14 R 64 66
INSULIN SYRINGE 58 28 65 80
METOCLOPRAMIDE HCL 56 24 66 102
AMLODIPINE BESYLATE-BENAZEPRIL 55 51 67 50
AMITRIPTYLINE HCL 55 12 R 67 48
OXYCODONE-ACETAMINOPHEN 54 35 S2 69 187
ADVAIR DISKUS 53 33 70 68
TRAZODONE HCL 53 12 70 35
FLUCONAZOLE 51 16 72 111
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 32 72 95
MORPHINE SULFATE ER 51 0 S2 72 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.